Status:

COMPLETED

18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas

Lead Sponsor:

Nantes University Hospital

Conditions:

Tumor

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of the study is to evaluate whether the TEP-CT can be sensitive and specific in identifying degenerated intraductal papillary mucinous tumor of the pancreas.The results will be compared to tho...

Detailed Description

Before surgery is undertaken, a 18 fluoro-deoxy-glucose positrons emission tomography combined with computed tomography (18-FDG TEP-CT ) will be performed. The primary outcome of this study is to comp...

Eligibility Criteria

Inclusion

  • Adults with age equal or above 18
  • Patients diagnosed with intraductal papillary mucinous tumor with surgical indication and for whom it will be possible to have the pathological analysis of the removed piece of pancreas.
  • if woman being of childbearing potential, woman taking contraceptive measures
  • Patient able to understand benefits and risks of protocol
  • Subject affiliated to French health insurance (Social Security)
  • Informed consent form signed

Exclusion

  • Patients not fulfilling inclusion criteria
  • Pancreatic surgery or radiotherapy in the pancreatic zone within 4 the months preceding the TEP-CT
  • Chemotherapy within 2 the months preceding the TEP-CT
  • Acute pancreatitis within 2 the months preceding the TEP-CT
  • Pregnant women or breast-feeding women refusing to temporary stop it
  • Diabetes not equilibrated (checked by glycemia and glycosylated hemoglobin (HbA1c) at inclusion) or Fasting blood glucose below 7mmol/L (126 g/L before the TEP)
  • Patients with claustrophobia
  • Patients not accepted under the anesthesia point of view

Key Trial Info

Start Date :

January 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2015

Estimated Enrollment :

126 Patients enrolled

Trial Details

Trial ID

NCT01485679

Start Date

January 1 2011

End Date

April 1 2015

Last Update

May 18 2016

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

CHU Nord

Amiens, France, France, 80080

2

Maison de Haut Lévêque CHU

Bordeaux, France, France, 33604

3

Hôpital Beaujon APHP

Clichy, France, France, 92110

4

Hôpital C Huriez

Lille, France, France, 59037